Mammographic screening: case–control studies

Mammographic screening: case-control studies.

BACKGROUND The case-control design can be used to evaluate the benefit of cancer screening programmes. MATERIALS AND METHODS This paper outlines the main methodological features of the case-control design in this context, and indicates some potential biases. It also reviews the existing case-control literature on mammographic screening. RESULTS Case-control studies consistently indicate a r...

Mammographic Screening for Breast Cancer

1. Reisberg B, Doody R, Stöffler A, et al. Memantine in moderateto-severe Alzheimer’s disease. N Engl J Med 2003;348:1333-4. 2. Kornhuber J, Bormann J, Retz W, Hübers M, Riederer P. Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 1989;166:589-90. 3. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for de...

Improving rates of mammographic screening.

Mammographic Screening for Breast Cancer

N Engl J Med 2003;348:1672-80. Copyright © 2003 Massachusetts Medical Society. A 44-year-old woman who is a new patient has no known current health problems and no family history of breast or ovarian cancer. Eighteen months ago, she had a normal screening mammogram. She recently read that mammograms may not help to prevent death from breast cancer and that “the patient should decide.” But she d...

GPCALMA: a Grid Approach to Mammographic Screening

The next generation of High Energy Physics experiments requires a GRID approach to a distributed computing system and the associated data management: the key concept is the V̈irtual Organisation(̈VO), a group of geographycally distributed users with a common goal and the will to share their resources. A similar approach is being applied to a group of Hospitals which joined the GPCALMA project (Gr...